查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827748

2025年活細胞成像全球市場報告

Live Cell Imaging Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，活細胞成像市場快速擴張，市場規模從2024年的49.9億美元成長至2025年的56.7億美元，複合年成長率達13.7%。預測期內的成長主要源自於藥物研發、癌症研究、生物技術和生物製藥、臨床應用以及細胞和分子生物學等領域。

預計未來幾年活細胞成像市場規模將快速成長，到2029年將達到98.6億美元，複合年成長率為14.8%。預測期內的成長可歸因於感染疾病研究、個人化醫療的採用、環境和生態研究、感染疾病研究以及免疫療法的發展。預測期內的主要趨勢包括3D和4D成像、超高解析度顯微鏡、高內涵篩檢、活細胞追蹤軟體以及微流體設備。

活細胞成像是指對活細胞進行體內成像，用於診斷和治療目的。相關儀器能夠詳細觀察細胞內部結構和細胞過程，有助於更深入了解細胞生物學。

活細胞影像產品主要分為儀器、耗材和軟體。活細胞影像技術包括延時顯微鏡、光漂白後螢光恢復 (FRAP)、螢光共振能量轉移 (FRET) 和高內涵篩檢(HCS)。活細胞成像應用範圍廣泛，包括細胞生物學、發育生物學、幹細胞和藥物研發。它被製藥和生物技術公司、學術研究機構以及委外研發機構(CRO) 廣泛採用。

2025年春季，美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供活細胞成像市場統計數據，例如全球活細胞成像行業規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的活細胞成像細分市場、市場趨勢和商業機會，以及您在活細胞成像行業取得成功所需的數據。本活細胞成像市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全方位觀點。

未來五年14.8%的預測成長率與我們先前對該市場的預測保持不變。這一下降主要源自於美國與其他國家之間關稅的影響。美國可能會透過對來自荷蘭和丹麥等主要地區的環境控制室和高靈敏度電荷耦合元件 (CCD) 相機徵收關稅，直接感受到這一影響。

預計預測期內，癌症發生率的上升將推動活細胞成像市場的成長。癌症是全球第二大死因，每年六分之一的死亡是由癌症引起的。例如，2024 年 7 月，專注於提供全面的健康和福利數據和分析的澳洲政府機構澳洲健康與福利研究所報告稱，澳洲確診的癌症病例數將從 2021 年的 156,781 例增加到 2022 年的 160,570 例，同比成長 3,789 例。活細胞成像技術對於癌症免疫療法的進步和檢驗至關重要，因為它能夠可視化、表徵和評估活細胞中的生物過程。因此，癌症發生率的上升促進了活細胞成像市場的成長。

個人化醫療需求的蓬勃發展推動著活細胞成像市場的發展。個人化醫療透過根據每位患者獨特的基因、分子和細胞特徵，為其量身定做治療決策、干預措施和藥物療法，徹底改變了治療方案。這種方法對於活細胞成像至關重要，它能夠根據個體特定的生物學特徵量身定做治療方案。例如，到2022年10月，將有超過75,000種基因檢測產品和超過300種個人化醫療產品，這標誌著個人化醫療的普及度不斷提高，並最終推動活細胞成像市場的成長。

活細胞成像市場成長的一個潛在限制因素是熟練專業人員的短缺。活細胞成像技術的複雜性要求具備高技能、精通理解和研究細胞功能的專業人員。報告顯示，未來十年，英國和歐洲將面臨嚴重的實驗室技能短缺，其中醫療實驗室將受到最大影響。蓋茲比基金會的研究表明，到2030年底，英國將需要額外70萬名技術人員來支持其經濟發展。熟練專業人員的短缺可能會在未來幾年阻礙市場成長。

活細胞成像市場的主要企業正透過開發創新產品來提升收益。新一代活細胞影像分析系統 CytoSMART Omni FL 就是一個顯著的例子。該系統首次將紅色和綠色螢光通道引入 CytoSMART Omni 產品線，能夠在各種透明細胞培養容器中創建高品質的明場和高通量活細胞螢光影像。總部位於荷蘭的 CytoSMART Technologies 於 2022 年 4 月推出了這款多功能且靈活的設備，展現了其在活細胞成像市場的持續創新。

2022年3月，美國生命科學公司Axion BioSystems收購了CytoSMART Technologies，具體金額未揭露。此次策略性收購旨在進一步拓展Axion在幹細胞研究和免疫腫瘤學領域的業務，並充分利用CytoSMART Technologies在活細胞成像領域的專業知識。

活細胞成像市場的主要參與者包括 Leica Microsystems GmbH、Olympus Corporation、Sigma-Aldrich Corporation、PerkinElmer Inc.、GE Healthcare Technologies Inc.、Carl Zeiss Meditec AG、Becton Dickinson and Company、Molecular Devices LLC、Bruker Corporation、Sartorius AG、Oxford Instru​​yal Inc. Biotech Corp.、CYTENA GmbH、Nanolive SA、Abberior GmbH、Phase Holographic Imaging AB、Cytoskeleton Inc.、Corning Incorporated、KEYENCE Corporation、Aligned Genetics Inc.、Axion BioSystems Inc.、Bio-Rad Laboratories Inc.、Nanob Technologies Inc.、Danok Technologies Inc.、Biocus、Sage Technologies Inc.、Nanob Technologies Inc.、C. Technologies Inc.Y.、Y.Sa Technologies Inc.）

2024 年，北美是活細胞成像市場最大的地區。活細胞成像市場分析報告涵蓋的地區包括亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

活細胞成像市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

活細胞成像市場涵蓋光學顯微鏡、物鏡、配件和試劑的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球活細胞成像：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球活細胞成像市場：成長率分析
  • 全球活細胞成像市場表現：規模與成長，2019-2024
  • 全球活細胞成像市場預測：規模與成長，2024-2029 年，2034 年
  • 全球活細胞成像：總目標市場（TAM）

第6章 市場細分

  • 全球活細胞成像市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 耗材
  • 軟體
  • 全球活細胞成像市場：按技術、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 延時顯微鏡
  • 光漂白後螢光恢復（FRAP）
  • 螢光共振能量轉移（FRET）
  • 高內涵篩檢（HCS）
  • 其他技術
  • 全球活細胞成像市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 細胞生物學
  • 發育生物學
  • 幹細胞與藥物發現
  • 其他用途
  • 全球活細胞成像市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 製藥和生物技術公司
  • 學術研究機構
  • 合約研究組織（CRO）
  • 全球活細胞成像市場：按設備類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 顯微鏡
  • 影像系統
  • 光片顯微鏡
  • 攝影機和檢測器
  • 全球活細胞成像市場：按耗材（類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 細胞培養板和培養皿
  • 試劑和染色劑
  • 媒體和補充資料
  • 影像感測器
  • 全球活細胞成像市場：按軟體（類型）細分、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 影像分析軟體
  • 資料管理軟體
  • 視覺化軟體
  • 影像處理工具

第7章 區域和國家分析

  • 全球活細胞成像市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球活細胞成像市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 活細胞成像市場：競爭格局
  • 活細胞成像市場：公司簡介
    • Leica Microsystems GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Leica Microsystems GmbH Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Carl Zeiss Meditec AG
  • Becton Dickinson and Company
  • Molecular Devices LLC
  • Bruker Corporation
  • Sartorius AG
  • Oxford Instruments plc
  • BioTek Instruments Inc.
  • Etaluma Inc.
  • CytoSMART Technologies BV
  • Blue-Ray Biotech Corp.
  • CYTENA GmbH
  • Nanolive SA
  • Abberior GmbH
  • Phase Holographic Imaging AB
  • Cytoskeleton Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年活細胞影像市場：提供新機會的國家
  • 2029年活細胞成像市場：細分領域帶來新機會
  • 2029年活細胞影像市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r21727u

Live cell imaging involves the in vivo imaging of living cells, serving diagnostic and treatment purposes. The associated equipment enables a detailed examination of internal structures and cellular processes, contributing to a deeper understanding of cell biology.

Live cell imaging products are primarily categorized into equipment, consumables, and software. The technologies utilized in live cell imaging encompass time-lapse microscopy, fluorescence recovery after photobleaching (FRAP), fluorescence resonance energy transfer (FRET), high content screening (HCS), among others. Applications of live cell imaging extend to cell biology, developmental biology, stem cell and drug discovery, and various other fields. It is widely employed in sectors such as pharmaceutical and biotechnology companies, academic and research institutes, as well as contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The live cell imaging market research report is one of a series of new reports from The Business Research Company that provides live cell imaging market statistics, including live cell imaging industry global market size, regional shares, competitors with a live cell imaging market share, detailed live cell imaging market segments, market trends and opportunities, and any further data you may need to thrive in the live cell imaging industry. This live cell imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The live cell imaging market size has grown rapidly in recent years. It will grow from $4.99 billion in 2024 to $5.67 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to drug discovery and development, cancer research, biotechnology and biopharmaceuticals, clinical applications, cellular and molecular biology.

The live cell imaging market size is expected to see rapid growth in the next few years. It will grow to $9.86 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to infectious disease research, adoption of personalized medicine, environmental and ecological research, infectious disease research, immunotherapy development. Major trends in the forecast period include 3D and 4d imaging, super-resolution microscopy, high-content screening, live-cell tracking software, microfluidic devices.

The forecast of 14.8% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on environmental control chambers and high-sensitivity charge-coupled device (CCD) cameras, sourced from key regions such as the Netherlands and Denmark, which could lead to compromised cellular research and increased costs for biological imaging systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is anticipated to drive the growth of the live cell imaging market during the forecast period. Cancer is the second leading cause of death globally, accounting for one in every six fatalities each year. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia focused on providing comprehensive health and welfare data and analysis, reported that the number of cancer cases diagnosed in Australia rose from 156,781 in 2021 to 160,570 in 2022, reflecting an increase of 3,789 cases over that year. Live cell imaging technology is essential for advancing and validating cancer immunotherapy by enabling the visualization, characterization, and evaluation of biological processes in living cells. Consequently, the rising incidence of cancer contributes to the growth of the live cell imaging market.

The burgeoning demand for personalized medicine is set to propel the live cell imaging market forward. Personalized medicine revolutionizes medical treatment by tailoring decisions, interventions, and drug therapies to the individual patient based on their unique genetic, molecular, and cellular characteristics. This approach proves invaluable for live cell imaging, enabling customization of medical treatments to an individual's specific biological traits. For example, by October 2022, there were over 75,000 genetic testing products and 300 personalized medicines, showcasing the increasing adoption of personalized medicine and, consequently, driving the growth of the live cell imaging market.

The potential constraint in the growth of the live cell imaging market is the lack of skilled professionals. The intricate nature of live cell imaging technology demands highly skilled professionals proficient in understanding and studying cellular functions. Reports indicate a severe shortage of laboratory skills in the UK and Europe over the next decade, with medical laboratories among the most affected. The Gatsby Foundation's research suggests that the UK will need an additional 700,000 technicians by the end of 2030 to support the economy. This shortage of skilled professionals poses a potential impediment to market growth in the coming years.

Leading companies in the live cell imaging market are driving revenue through the development of innovative products. The CytoSMART Omni FL, a next-generation live-cell imaging analysis system, is a notable example. This system introduces red and green fluorescence channels into the CytoSMART Omni product line for the first time, enabling the production of high-quality brightfield or high-throughput fluorescence images of living cells in various transparent cell culture vessels. CytoSMART Technologies, a Netherlands-based company, launched this versatile and flexible device in April 2022, showcasing the continuous innovation in the live cell imaging market.

In March 2022, Axion BioSystems, a US-based life sciences company, acquired CytoSMART Technologies for an undisclosed amount. This strategic acquisition aims to facilitate Axion's expansion into stem cell research and immuno-oncology, leveraging the expertise of CytoSMART Technologies in the field of live cell imaging.

Major companies operating in the live cell imaging market include Leica Microsystems GmbH, Olympus Corporation, Sigma-Aldrich Corporation, PerkinElmer Inc., GE Healthcare Technologies Inc., Carl Zeiss Meditec AG, Becton Dickinson and Company, Molecular Devices LLC, Bruker Corporation, Sartorius AG, Oxford Instruments plc, BioTek Instruments Inc., Etaluma Inc., CytoSMART Technologies B.V., Blue-Ray Biotech Corp., CYTENA GmbH, Nanolive SA, Abberior GmbH, Phase Holographic Imaging AB, Cytoskeleton Inc., Corning Incorporated, KEYENCE Corporation, Aligned Genetics Inc., Axion BioSystems Inc., Bio-Rad Laboratories Inc., NanoEnTek Inc., Danaher Corporation, Agilent Technologies Inc., Leinco Technologies, Phasefocus Ltd.

North America was the largest region in the live cell imaging market in 2024. The regions covered in the live cell imaging market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the live cell imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The live cell imaging market consists of sales of light microscopes, objective lenses, accessories, and reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Live Cell Imaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on live cell imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for live cell imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The live cell imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Equipment; Consumable; Software
  • 2) By Technology: Time-Lapse Microscopy; Fluorescence Recovery After Photobleaching (FRAP); Fluorescence Resonance Energy Transfer (FRET); High Content Screening (HCS); Other Technologies
  • 3) By Application: Cell Biology; Developmental Biology; Stem Cell and Drug Discovery; Other Applications
  • 4) By End-User: Pharmaceutical and Biotechnology Companies; Academic and Research Institutes; Contract Research Organizations (CROs)
  • Subsegments:
  • 1) By Equipment: Microscopes; Imaging Systems; Light Sheet Microscopes; Cameras And Detectors
  • 2) By Consumable: Cell Culture Plates And Dishes; Reagents And Stains; Media And Supplements; Imaging Sensors
  • 3) By Software: Image Analysis Software; Data Management Software; Visualization Software; Image Processing Tools
  • Companies Mentioned: Leica Microsystems GmbH; Olympus Corporation; Sigma-Aldrich Corporation; PerkinElmer Inc.; GE Healthcare Technologies Inc.; Carl Zeiss Meditec AG; Becton Dickinson and Company; Molecular Devices LLC; Bruker Corporation; Sartorius AG; Oxford Instruments plc; BioTek Instruments Inc.; Etaluma Inc.; CytoSMART Technologies B.V.; Blue-Ray Biotech Corp.; CYTENA GmbH; Nanolive SA; Abberior GmbH; Phase Holographic Imaging AB; Cytoskeleton Inc.; Corning Incorporated; KEYENCE Corporation; Aligned Genetics Inc.; Axion BioSystems Inc.; Bio-Rad Laboratories Inc.; NanoEnTek Inc.; Danaher Corporation; Agilent Technologies Inc.; Leinco Technologies; Phasefocus Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Live Cell Imaging Market Characteristics

3. Live Cell Imaging Market Trends And Strategies

4. Live Cell Imaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Live Cell Imaging Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Live Cell Imaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Live Cell Imaging Market Growth Rate Analysis
  • 5.4. Global Live Cell Imaging Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Live Cell Imaging Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Live Cell Imaging Total Addressable Market (TAM)

6. Live Cell Imaging Market Segmentation

  • 6.1. Global Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Equipment
  • Consumable
  • Software
  • 6.2. Global Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Time-Lapse Microscopy
  • Fluorescence Recovery After Photobleaching (FRAP)
  • Fluorescence Resonance Energy Transfer (FRET)
  • High Content Screening (HCS)
  • Other Technologies
  • 6.3. Global Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Biology
  • Developmental Biology
  • Stem Cell and Drug Discovery
  • Other Applications
  • 6.4. Global Live Cell Imaging Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations (CROs)
  • 6.5. Global Live Cell Imaging Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microscopes
  • Imaging Systems
  • Light Sheet Microscopes
  • Cameras And Detectors
  • 6.6. Global Live Cell Imaging Market, Sub-Segmentation Of Consumable, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Culture Plates And Dishes
  • Reagents And Stains
  • Media And Supplements
  • Imaging Sensors
  • 6.7. Global Live Cell Imaging Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Image Analysis Software
  • Data Management Software
  • Visualization Software
  • Image Processing Tools

7. Live Cell Imaging Market Regional And Country Analysis

  • 7.1. Global Live Cell Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Live Cell Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Live Cell Imaging Market

  • 8.1. Asia-Pacific Live Cell Imaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Live Cell Imaging Market

  • 9.1. China Live Cell Imaging Market Overview
  • 9.2. China Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Live Cell Imaging Market

  • 10.1. India Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Live Cell Imaging Market

  • 11.1. Japan Live Cell Imaging Market Overview
  • 11.2. Japan Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Live Cell Imaging Market

  • 12.1. Australia Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Live Cell Imaging Market

  • 13.1. Indonesia Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Live Cell Imaging Market

  • 14.1. South Korea Live Cell Imaging Market Overview
  • 14.2. South Korea Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Live Cell Imaging Market

  • 15.1. Western Europe Live Cell Imaging Market Overview
  • 15.2. Western Europe Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Live Cell Imaging Market

  • 16.1. UK Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Live Cell Imaging Market

  • 17.1. Germany Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Live Cell Imaging Market

  • 18.1. France Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Live Cell Imaging Market

  • 19.1. Italy Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Live Cell Imaging Market

  • 20.1. Spain Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Live Cell Imaging Market

  • 21.1. Eastern Europe Live Cell Imaging Market Overview
  • 21.2. Eastern Europe Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Live Cell Imaging Market

  • 22.1. Russia Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Live Cell Imaging Market

  • 23.1. North America Live Cell Imaging Market Overview
  • 23.2. North America Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Live Cell Imaging Market

  • 24.1. USA Live Cell Imaging Market Overview
  • 24.2. USA Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Live Cell Imaging Market

  • 25.1. Canada Live Cell Imaging Market Overview
  • 25.2. Canada Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Live Cell Imaging Market

  • 26.1. South America Live Cell Imaging Market Overview
  • 26.2. South America Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Live Cell Imaging Market

  • 27.1. Brazil Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Live Cell Imaging Market

  • 28.1. Middle East Live Cell Imaging Market Overview
  • 28.2. Middle East Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Live Cell Imaging Market

  • 29.1. Africa Live Cell Imaging Market Overview
  • 29.2. Africa Live Cell Imaging Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Live Cell Imaging Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Live Cell Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Live Cell Imaging Market Competitive Landscape And Company Profiles

  • 30.1. Live Cell Imaging Market Competitive Landscape
  • 30.2. Live Cell Imaging Market Company Profiles
    • 30.2.1. Leica Microsystems GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Leica Microsystems GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Live Cell Imaging Market Other Major And Innovative Companies

  • 31.1. Carl Zeiss Meditec AG
  • 31.2. Becton Dickinson and Company
  • 31.3. Molecular Devices LLC
  • 31.4. Bruker Corporation
  • 31.5. Sartorius AG
  • 31.6. Oxford Instruments plc
  • 31.7. BioTek Instruments Inc.
  • 31.8. Etaluma Inc.
  • 31.9. CytoSMART Technologies B.V.
  • 31.10. Blue-Ray Biotech Corp.
  • 31.11. CYTENA GmbH
  • 31.12. Nanolive SA
  • 31.13. Abberior GmbH
  • 31.14. Phase Holographic Imaging AB
  • 31.15. Cytoskeleton Inc.

32. Global Live Cell Imaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Live Cell Imaging Market

34. Recent Developments In The Live Cell Imaging Market

35. Live Cell Imaging Market High Potential Countries, Segments and Strategies

  • 35.1 Live Cell Imaging Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Live Cell Imaging Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Live Cell Imaging Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer